Uganda Now Makes Sickle Cell Drug, Cutting Costs for 20K Babies

Uganda has started producing Hydroxyurea locally, a breakthrough drug that treats sickle cell disease affecting 20,000 newborns each year.

The move slashes costs and makes life-saving treatment accessible to families who've struggled with expensive imports.